WELLS FARGO HEALTHCARE CONFERENCE PRESENTATION

Company

HALOZYME THERAPEUTICS, INC.

Filed

September 4, 2019

Period of Report

September 4, 2019

Accession Number

0001159036-19-000046

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →